Benjamin Graham fit · Defensive deep-value investing
Is Globus Medical, Inc. (GMED) a Benjamin Graham Stock?
Meets 4/7 Graham criteria - partially qualifies.
63/100
CMixed signals
4/7 criteria passed
+6 sector-quality lift. Top-quintile within its sector on 3 of 5 quality metrics. Raw pillar score 57 → lifted to 63 before grade derivation.
Benjamin Graham's Criteria, Applied to GMED
P/E ≤ 15
key17.7x
P/B ≤ 1.5
key2.2x
Current ratio ≥ 2
4.6x
Debt / Equity ≤ 1
0.0x
5y profitable
keyYes
Earnings yield ≥ 7%
5.7%
Revenue growing
32.3%
How GMED Scores on Other Strategies
Live Financial Snapshot
Market cap
$11.11B
P/E (TTM)
17.7x
ROIC (TTM)
9.72%
Gross margin
67.86%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is GMED's Benjamin Graham fit score?
GMED scores 63/100 on our Benjamin Graham fit engine - grade C. Meets 4/7 Graham criteria - partially qualifies.
Does Benjamin Graham actually own GMED?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends GMED.
How often is this score updated?
GMED's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends GMED.